MacroGenics
MARGENZA
Manufacturer:
MacroGenics
Name:
MARGENZA
HCPCS Code Descriptor:
Injection, margetuximab-cmkb, 5 mg
Category:
J Code
HCPCS:
J9353
NDC(s):
74527-0022-02, 74527-0022-03
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
MARGENZA is an Oncology drug manufactured by MacroGenics and administered via the Intravenous route of administration. The J Code: J9353 is aligned to the drug MARGENZA.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/21
HCPCS Effective Date:
7/1/21
HCPCS Short Description:
Inj. margetuximab-cmkb, 5 mg
Billing and Coding Guide:
https://www.margenza.com/pdf/margenza-billing-and-coding-guide.pdf
Patient Assistance:
https://www.margenzasupport.com/
